CB: Pathology and Tissue Procurement Core
CB:病理学和组织采购核心
基本信息
- 批准号:7450239
- 负责人:
- 金额:$ 12.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBiological MarkersBiologyBlood specimenCaringCentral Nervous System NeoplasmsClinicalCollaborationsDataDatabasesEvaluationExperimental NeoplasmsGliomaHistologicInvestigationMalignant neoplasm of brainNervous system structureNormal tissue morphologyPathologicPathologyPatientsProcessReproduction sporesResearch PersonnelSamplingServicesSpecimenTissue MicroarrayTissue ProcurementsTissue SampleTissuesTranslational ResearchTumor TissueUniversity of Texas M D Anderson Cancer Centerdesign and constructionhuman tissueimprovedprospectiverepositorytissue resourcetreatment effecttumor
项目摘要
The specific objectives of the Pathology and Tissue Procurement Core are to:
Objective 1 Maintain and enhance a repository of tumor tissue and matched blood specimens from
patients with central nervous system (CNS) tumors receiving care at The University of
Texas M. D. Anderson Cancer Center (UTMDACC).
Objective 2 Provide comprehensive histologic characterization of tissue samples used in the SPORE
Projects, including specimens from patients and experimental tumors in animals;
expeditiously distribute tissue specimens to SPORE investigators for analysis; and provide
expertise in the interpretation of studies performed on tissue sections within the SPORE
Projects.
Objective 3 Offer centralized services, including immunohistochemical characterization of biomarkers,
tissue array design and construction, and primary culture of tumor samples where
appropriate.
Objective 4 Support a comprehensive, prospective interactive database with detailed clinical and
pathologic data for patients with CNS tumors receiving care or evaluation at UTMDACC.
Objective 5 Facilitate inter-SPORE collaborations through sharing of tissue resources.
病理学和组织采购核心的具体目标是:
目标 1 维护和增强肿瘤组织和匹配血液样本的存储库
中枢神经系统 (CNS) 肿瘤患者在英国大学接受护理
德克萨斯MD安德森癌症中心(UTMDACC)。
目标 2 提供 SPORE 中使用的组织样本的全面组织学特征
项目,包括患者标本和动物实验肿瘤;
迅速将组织标本分发给 SPORE 研究人员进行分析;并提供
解释 SPORE 内组织切片研究的专业知识
项目。
目标 3 提供集中服务,包括生物标志物的免疫组织化学表征、
组织阵列设计和构建,以及肿瘤样本的原代培养
合适的。
目标 4 支持一个全面的、前瞻性的交互式数据库,其中包含详细的临床和
在 UTMDACC 接受护理或评估的中枢神经系统肿瘤患者的病理数据。
目标 5 通过共享组织资源促进 SPORE 之间的合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH D ALDAPE其他文献
KENNETH D ALDAPE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH D ALDAPE', 18)}}的其他基金
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOM
建立精细的胶质母细胞分子递归分区分析模型
- 批准号:
7944134 - 财政年份:2009
- 资助金额:
$ 12.39万 - 项目类别:
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOM
建立精细的胶质母细胞分子递归分区分析模型
- 批准号:
7853814 - 财政年份:2009
- 资助金额:
$ 12.39万 - 项目类别:
Predictive Markers to Personalize Medicine for Malignant Glioma
恶性胶质瘤个性化医疗的预测标记
- 批准号:
8588569 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
Predictive Markers to Personalize Medicine for Malignant Glioma
恶性胶质瘤个性化医疗的预测标记
- 批准号:
8753978 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
Predictive Markers to Personalize Medicine for Malignant Glioma
恶性胶质瘤个性化医疗的预测标记
- 批准号:
8918452 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
Prediction of Chemoradiation response in Glioblastoma to individualize Therapy
预测胶质母细胞瘤的放化疗反应以进行个体化治疗
- 批准号:
7450205 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
Predictive Markers to Personalize Medicine for Malignant Glioma
恶性胶质瘤个性化医疗的预测标记
- 批准号:
9128424 - 财政年份:2008
- 资助金额:
$ 12.39万 - 项目类别:
相似海外基金
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10490338 - 财政年份:2021
- 资助金额:
$ 12.39万 - 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10353104 - 财政年份:2021
- 资助金额:
$ 12.39万 - 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
- 批准号:
21K04320 - 财政年份:2021
- 资助金额:
$ 12.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10688286 - 财政年份:2021
- 资助金额:
$ 12.39万 - 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
- 批准号:
20K17755 - 财政年份:2020
- 资助金额:
$ 12.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10578649 - 财政年份:2019
- 资助金额:
$ 12.39万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10295141 - 财政年份:2019
- 资助金额:
$ 12.39万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10041708 - 财政年份:2019
- 资助金额:
$ 12.39万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
9776149 - 财政年份:2019
- 资助金额:
$ 12.39万 - 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
- 批准号:
2063934 - 财政年份:2018
- 资助金额:
$ 12.39万 - 项目类别:
Studentship














{{item.name}}会员




